|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,105 JPY | +0.16% |
|
+0.06% | +6.83% |
| Apr. 09 | H. Lundbeck, Otsuka Pharmaceutical Seek US FDA Nod for PTSD Combination Therapy | MT |
| Mar. 29 | Otsuka Holdings Disposes of 2.32 Billion Yen Worth of Shares as Restricted Stock Compensation | MT |
Otsuka Corporation reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was JPY 977,370 million. Net income was JPY 47,448 million.
Basic earnings per share from continuing operations was JPY 125.13.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.83% | 7.48B | |
| -7.42% | 31.57B | |
| +0.21% | 15.14B | |
| -6.71% | 8.91B | |
| +3.85% | 4.94B | |
| -45.75% | 4.44B | |
| +12.35% | 2.99B | |
| +8.53% | 2.44B | |
| -13.45% | 2.36B | |
| -15.17% | 2.06B |
OTSUKA CORPORATION 
